CommercialCoverageMedium impact
Member Benefit Coverage for Viscosupplementation for Osteoarthritis will End Jan. 1, 2026
BCBS Texas·TX · Orthopedics, Rheumatology, Family Medicine +2 more·General
Effective date
Jan 1, 2026
We identified it
Jan 12, 2026
Summary
Blue Cross Blue Shield of Texas will discontinue coverage for viscosupplementation injections for osteoarthritis treatment effective January 1, 2026. Some members currently receiving maintenance injections may continue coverage through 2026 and will be notified directly.
Action Required
Before January 1, 2026: Billing team must update systems to flag viscosupplementation procedures for osteoarthritis as non-covered for BCBSTX commercial members. Verify eligibility and benefits through Availity Essentials before rendering services. For patients currently on maintenance therapy, confirm individual coverage continuation through member notifications.